These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 19220238)

  • 1. First trimester urinary placental growth factor and development of pre-eclampsia.
    Savvidou MD; Akolekar R; Zaragoza E; Poon LC; Nicolaides KH
    BJOG; 2009 Apr; 116(5):643-7. PubMed ID: 19220238
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low urinary placental growth factor is a marker of pre-eclampsia.
    Aggarwal PK; Jain V; Sakhuja V; Karumanchi SA; Jha V
    Kidney Int; 2006 Feb; 69(3):621-4. PubMed ID: 16395263
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urinary placental growth factor and risk of preeclampsia.
    Levine RJ; Thadhani R; Qian C; Lam C; Lim KH; Yu KF; Blink AL; Sachs BP; Epstein FH; Sibai BM; Sukhatme VP; Karumanchi SA
    JAMA; 2005 Jan; 293(1):77-85. PubMed ID: 15632339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. First-trimester placental protein 13 and placental growth factor: markers for identification of women destined to develop early-onset pre-eclampsia.
    Wortelboer EJ; Koster MP; Cuckle HS; Stoutenbeek PH; Schielen PC; Visser GH
    BJOG; 2010 Oct; 117(11):1384-9. PubMed ID: 20840693
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Urinary placental growth factor differentiates the hypertensive disorders of pregnancy.
    Campbell N; Ogle R; Thornton C; Hennessy A; Abbott J
    Aust N Z J Obstet Gynaecol; 2011 Dec; 51(6):523-6. PubMed ID: 21883135
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is serum placental growth factor more effective as a biomarker in predicting early onset preeclampsia in early second trimester than in first trimester of pregnancy?
    Ghosh SK; Raheja S; Tuli A; Raghunandan C; Agarwal S
    Arch Gynecol Obstet; 2013 May; 287(5):865-73. PubMed ID: 23224699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prediction of pre-eclampsia in early pregnancy by estimating the spot urinary albumin: creatinine ratio using high-performance liquid chromatography.
    Baweja S; Kent A; Masterson R; Roberts S; McMahon LP
    BJOG; 2011 Aug; 118(9):1126-32. PubMed ID: 21481153
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of urinary soluble endoglin in the diagnosis of pre-eclampsia: comparison with soluble fms-like tyrosine kinase 1 to placental growth factor ratio.
    Buhimschi CS; Baumbusch MA; Dulay AT; Lee S; Wehrum M; Zhao G; Bahtiyar MO; Pettker CM; Ali UA; Funai EF; Buhimschi IA
    BJOG; 2010 Feb; 117(3):321-30. PubMed ID: 19943826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maternal serum placental growth factor isoforms 1 and 2 at 11-13, 20-24 and 30-34 weeks' gestation in late-onset pre-eclampsia and small for gestational age neonates.
    Nucci M; Poon LC; Demirdjian G; Darbouret B; Nicolaides KH
    Fetal Diagn Ther; 2014; 35(4):249-57. PubMed ID: 24642536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Maternal serum placental growth factor at 11 + 0 to 13 + 6 weeks of gestation in the prediction of pre-eclampsia.
    Akolekar R; Zaragoza E; Poon LC; Pepes S; Nicolaides KH
    Ultrasound Obstet Gynecol; 2008 Nov; 32(6):732-9. PubMed ID: 18956425
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endoglin, PlGF and sFlt-1 as markers for predicting pre-eclampsia.
    De Vivo A; Baviera G; Giordano D; Todarello G; Corrado F; D'anna R
    Acta Obstet Gynecol Scand; 2008; 87(8):837-42. PubMed ID: 18607829
    [TBL] [Abstract][Full Text] [Related]  

  • 12. First trimester placental growth factor and soluble fms-like tyrosine kinase 1 and risk for preeclampsia.
    Thadhani R; Mutter WP; Wolf M; Levine RJ; Taylor RN; Sukhatme VP; Ecker J; Karumanchi SA
    J Clin Endocrinol Metab; 2004 Feb; 89(2):770-5. PubMed ID: 14764795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating angiogenic factors and abnormal uterine artery Doppler velocimetry in the second trimester.
    Muller PR; James AH; Murtha AP; Yonish B; Jamison MG; Dekker G
    Hypertens Pregnancy; 2006; 25(3):183-92. PubMed ID: 17065039
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin resistance and alterations in angiogenesis: additive insults that may lead to preeclampsia.
    Thadhani R; Ecker JL; Mutter WP; Wolf M; Smirnakis KV; Sukhatme VP; Levine RJ; Karumanchi SA
    Hypertension; 2004 May; 43(5):988-92. PubMed ID: 15023932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Screening for pre-eclampsia using serum placental growth factor and endoglin with Down's syndrome Quadruple test markers.
    Wald NJ; Bestwick JP; George LM; Wu T; Morris JK
    J Med Screen; 2012 Jun; 19(2):60-7. PubMed ID: 22547409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Placental growth factor and soluble FMS-like tyrosine kinase-1 in early-onset and late-onset preeclampsia.
    Wikström AK; Larsson A; Eriksson UJ; Nash P; Nordén-Lindeberg S; Olovsson M
    Obstet Gynecol; 2007 Jun; 109(6):1368-74. PubMed ID: 17540809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early postpartum changes in circulating pro- and anti-angiogenic factors in early-onset and late-onset pre-eclampsia.
    Wikström AK; Larsson A; Eriksson UJ; Nash P; Olovsson M
    Acta Obstet Gynecol Scand; 2008; 87(2):146-53. PubMed ID: 18231881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. First-trimester maternal serum PP-13, PAPP-A and second-trimester uterine artery Doppler pulsatility index as markers of pre-eclampsia.
    Spencer K; Cowans NJ; Chefetz I; Tal J; Meiri H
    Ultrasound Obstet Gynecol; 2007 Feb; 29(2):128-34. PubMed ID: 17149788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. First-trimester maternal serum metastin, placental growth factor and chitotriosidase levels in pre-eclampsia.
    Madazli R; Bulut B; Tuten A; Aydin B; Demirayak G; Kucur M
    Eur J Obstet Gynecol Reprod Biol; 2012 Oct; 164(2):146-9. PubMed ID: 22770630
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prospective analysis of placenta growth factor (PlGF) concentrations in the plasma of women with normal pregnancy and pregnancies complicated by preeclampsia.
    Krauss T; Pauer HU; Augustin HG
    Hypertens Pregnancy; 2004; 23(1):101-11. PubMed ID: 15117604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.